Your browser doesn't support javascript.
loading
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
Kumbrink, Jörg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstöcker, Daniela; Li, Pan; Lorenzen, Sylvie; Algül, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; von Bergwelt-Baildon, Michael; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker; Holch, Julian W.
Afiliação
  • Kumbrink J; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Bohlmann L; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
  • Mamlouk S; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Redmer T; German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
  • Peilstöcker D; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Li P; Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Lorenzen S; Institute of Medical Biochemistry, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
  • Algül H; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Kasper S; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Hempel D; Klinikum Rechts der Isar, Technical University of Munich, III. Medizinische Klinik und Poliklinik, 81675 Munich, Germany.
  • Kaiser F; School of Medicine, Technical University of Munich, 81675 Munich, Germany.
  • Michl M; Comprehensive Cancer Center Munich, Technical University of Munich, Klinikum Rechts der Isar, 81675 Munich, Germany.
  • Bartsch H; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, 45147 Essen, Germany.
  • Neumann J; Steinbeishochschule Berlin, 12489 Berlin, Germany.
  • Klauschen F; Steinbeis Transfer Institute Clinical Hematology-Oncology, 86609 Donauwörth, Germany.
  • von Bergwelt-Baildon M; VK&K Studien GbR, 84036 Landshut, Germany.
  • Modest DP; Department of Medicine III, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Stahler A; Comprehensive Cancer Center, University Hospital, LMU Munich, 81377 Munich, Germany.
  • Stintzing S; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Jung A; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Kirchner T; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
  • Schäfer R; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, 80337 Munich, Germany.
  • Heinemann V; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
  • Holch JW; German Cancer Consortium (DKTK), Partner Site Munich, 80336 Munich, Germany.
Cancers (Basel) ; 14(15)2022 Jul 26.
Article em En | MEDLINE | ID: mdl-35892888
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article